Literature DB >> 33585201

Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure.

Gloria Taliani1,2,3, Elena Follini4, Lorenzo Guglielmetti1,5,6, Patrizia Bernuzzi4, Alberto Faggi1, Patrizia Ferrante1,7, Elisa Fronti1, Laura Gerna1, Maria Cristina Leoni1, Franco Paolillo1, Giovanna Ratti1, Alessandro Ruggieri1, Caterina Valdatta1, Alessandra Donisi8, Adriano Zangrandi9, Lara Pochintesta4, Carlo Moroni4, Daria Sacchini1, Daniele Vallisa4, Mauro Codeluppi1.   

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects humans through the angiotensin converting enzyme-2 (ACE-2) receptor expressed on many cells, including lymphocytes. In Covid-19 patients IL-6 is overexpressed, and hyperactivated plasmacytoid lymphocytes are detected in peripheral blood film. We hypothesize that, due to the unpredictable interaction between the new virus and the B cell lineage of infected patients, a cascade of out of control events can ensue, capable of determining unexpected pathologic disorders involving such lineage. Here we report two cases of autoimmune hemolytic anemia (AIHA) and two cases of B-cell hematological malignancies developed or reactivated during acute SARS-CoV-2 infection. The temporal relationship of the events may suggest a potential causal relationship between SARS-CoV-2 infection and the hematopoietic disorders. We suggest that special attention should be paid to COVID-19 patients with underlining B cell lineage disorders.
Copyright © 2021 Taliani, Follini, Guglielmetti, Bernuzzi, Faggi, Ferrante, Fronti, Gerna, Leoni, Paolillo, Ratti, Ruggieri, Valdatta, Donisi, Zangrandi, Pochintesta, Moroni, Sacchini, Vallisa, Codeluppi and the COVID-Piacenza Group.

Entities:  

Keywords:  B-cell lineage malignancies; COVID-19; acute lymphoblastic leukemia; autoimmune hemolytic anemia; multiple myeloma; reactivation

Year:  2021        PMID: 33585201      PMCID: PMC7874205          DOI: 10.3389/fonc.2020.582901

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  25 in total

Review 1.  Managing CNS disease in adults with acute lymphoblastic leukemia.

Authors:  Richard A Larson
Journal:  Leuk Lymphoma       Date:  2017-05-23

Review 2.  IL-6 as a keystone cytokine in health and disease.

Authors:  Christopher A Hunter; Simon A Jones
Journal:  Nat Immunol       Date:  2015-05       Impact factor: 25.606

Review 3.  Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.

Authors:  Susan J Lee; Ivan Borrello
Journal:  Cancer Treat Res       Date:  2016

Review 4.  Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir.

Authors:  Toshio Hirano
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 5.  Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma.

Authors:  Danielle Harmer; Carolyne Falank; Michaela R Reagan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-08       Impact factor: 5.555

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.

Authors:  Ai Tang Xiao; Yi Xin Tong; Sheng Zhang
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 20.693

8.  Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.

Authors:  Guangming Ye; Zhenyu Pan; Yunbao Pan; Qiaoling Deng; Liangjun Chen; Jin Li; Yirong Li; Xinghuan Wang
Journal:  J Infect       Date:  2020-03-20       Impact factor: 6.072

9.  Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.

Authors:  Fan Wang; Jiayan Nie; Haizhou Wang; Qiu Zhao; Yong Xiong; Liping Deng; Shihui Song; Zhiyong Ma; Pingzheng Mo; Yongxi Zhang
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

10.  First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.

Authors:  Xuhan Zhang; Kaidi Song; Fei Tong; Mingming Fei; Hui Guo; Zhaohui Lu; Jinquan Wang; Changcheng Zheng
Journal:  Blood Adv       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.